Project Details
Description
Protocol ATI001-102 Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Combination with Nivolumab in Subjects with Recurrent or Progressive Glioblastoma
| Status | Finished |
|---|---|
| Effective start/end date | 2/21/19 → 2/28/23 |
Funding
- ZIOPHARM ONCOLOGY, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.